Baxter completed its acquisition of Baxa Corporation in November 2011. This acquisition builds upon Baxter’s long-standing leadership in intravenous (IV) nutrition and fluid delivery. Together, we will be able to broaden the range of solutions available to meet your patients’ nutritional requirements, while increasing operational efficiency in the hospital pharmacy.
Our products, systems and professional services encompass virtually every facet of compounding and dispensing fluid medications. From the most basic devices for oral unit-dosing to complex IV admixture preparation, syringe infusion, multi-source solution compounding and compliance training for professionals, we are committed to patient safety and operational efficiency.